$ISIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IONIS PHARMACEUTICALS INC. Get notifications about new insider transactions in IONIS PHARMACEUTICALS INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 15,000 | 220,350 | 116,642 | |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.45 | 1,500 | 78,675 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.45 | 15,000 | 786,750 | 38,014 | 53 K to 38 K (-28.29 %) |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 15,000 | 220,350 | 53,014 | 38 K to 53 K (+39.46 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 51.35 | 309 | 15,867 | 11,626 | 11.9 K to 11.6 K (-2.59 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | J | 40.66 | 163 | 6,627 | 11,935 | 11.8 K to 11.9 K (+1.38 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | J | 40.66 | 90 | 3,659 | 25,741 | 25.7 K to 25.7 K (+0.35 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | J | 40.66 | 134 | 5,448 | 10,433 | 10.3 K to 10.4 K (+1.30 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | J | 40.66 | 104 | 4,228 | 10,392 | 10.3 K to 10.4 K (+1.01 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 40.66 | 196 | 7,968 | 13,158 | 13 K to 13.2 K (+1.51 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 40.66 | 17 | 691 | 5,269 | 5.3 K to 5.3 K (+0.32 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | J | 40.66 | 253 | 10,286 | 15,041 | 14.8 K to 15 K (+1.71 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 7,404 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 1,538 | 22,593 | 131,642 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 13,462 | 97,600 | 0 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.10 | 1,500 | 78,150 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.30 | 1,538 | 80,437 | 38,014 | 39.6 K to 38 K (-3.89 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 1,538 | 22,593 | 39,552 | 38 K to 39.6 K (+4.05 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.08 | 13,462 | 701,101 | 38,014 | 51.5 K to 38 K (-26.15 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 13,462 | 97,600 | 51,476 | 38 K to 51.5 K (+35.41 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 2,469 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 2,469 | 0 | 36,249 | 33.8 K to 36.2 K (+7.31 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 2,469 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 2,469 | 0 | 7,127 | 4.7 K to 7.1 K (+53.01 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 1,600 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 2,001 | 0 | 4,936 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 2,001 | 0 | 6,815 | 4.8 K to 6.8 K (+41.57 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 2,469 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 2,469 | 0 | 10,127 | 7.7 K to 10.1 K (+32.24 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 3,406 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 3,406 | 0 | 9,627 | 6.2 K to 9.6 K (+54.75 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 2,469 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 2,469 | 0 | 91,427 | 89 K to 91.4 K (+2.78 %) |
Jun 02 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 9.77 | 12,500 | 122,125 | 0 | |
Jun 02 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Sell | S | 45.22 | 12,500 | 565,250 | 4,658 | 17.2 K to 4.7 K (-72.85 %) |
Jun 02 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 9.77 | 12,500 | 122,125 | 17,158 | 4.7 K to 17.2 K (+268.36 %) |
Jun 02 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 70 | 757 | 1,700 | |
Jun 02 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 48.00 | 70 | 3,360 | 10,299 | 10.4 K to 10.3 K (-0.68 %) |
Jun 02 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 70 | 757 | 10,369 | 10.3 K to 10.4 K (+0.68 %) |
May 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 500 | 5,410 | 1,770 | |
May 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 48.75 | 500 | 24,375 | 10,299 | 10.8 K to 10.3 K (-4.63 %) |
May 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 500 | 5,410 | 10,799 | 10.3 K to 10.8 K (+4.85 %) |
May 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 48.75 | 150 | 7,313 | 10,299 | 10.4 K to 10.3 K (-1.44 %) |
Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 8,904 | |
Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 15,000 | 108,750 | 13,462 | |
Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 47.81 | 1,500 | 71,715 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 47.81 | 15,000 | 717,150 | 38,014 | 53 K to 38 K (-28.29 %) |
Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 15,000 | 108,750 | 53,014 | 38 K to 53 K (+39.46 %) |
Apr 26 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 426 | 4,609 | 3,500 | |
Apr 26 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 74 | 801 | 2,270 | |
Apr 26 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 45.00 | 426 | 19,170 | 10,449 | 10.9 K to 10.4 K (-3.92 %) |
Apr 26 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 426 | 4,609 | 10,875 | 10.4 K to 10.9 K (+4.08 %) |
Apr 26 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 45.00 | 74 | 3,330 | 10,449 | 10.5 K to 10.4 K (-0.70 %) |
Apr 26 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 74 | 801 | 10,523 | 10.4 K to 10.5 K (+0.71 %) |
Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 500 | 3,625 | 10,404 | |
Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 5,000 | 36,250 | 28,462 | |
Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 43.25 | 500 | 21,625 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 43.25 | 5,000 | 216,250 | 38,014 | 43 K to 38 K (-11.62 %) |
Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 5,000 | 36,250 | 43,014 | 38 K to 43 K (+13.15 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 40.07 | 1,000 | 40,070 | 10,449 | 11.4 K to 10.4 K (-8.73 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 500 | 3,625 | 10,904 | |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 500 | 5,145 | 0 | |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 33,462 | |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 500 | |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 43,462 | |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.30 | 500 | 20,650 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.30 | 500 | 20,650 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.30 | 10,000 | 413,000 | 38,014 | 48 K to 38 K (-20.83 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 10,000 | 72,500 | 48,014 | 38 K to 48 K (+26.31 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.07 | 1,000 | 40,070 | 3,062 | 4.1 K to 3.1 K (-24.62 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 4,062 | 3.1 K to 4.1 K (+32.66 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.07 | 10,000 | 400,700 | 38,014 | 48 K to 38 K (-20.83 %) |
Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 10,000 | 72,500 | 48,014 | 38 K to 48 K (+26.31 %) |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 10.29 | 5,000 | 51,450 | 22,250 | |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 55.00 | 5,000 | 275,000 | 14,788 | 19.8 K to 14.8 K (-25.27 %) |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 10.29 | 5,000 | 51,450 | 19,788 | 14.8 K to 19.8 K (+33.81 %) |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,100 | 11,319 | 1,500 | |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 11,000 | 79,750 | 53,462 | |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.05 | 1,100 | 56,155 | 3,062 | 4.2 K to 3.1 K (-26.43 %) |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,100 | 11,319 | 4,162 | 3.1 K to 4.2 K (+35.92 %) |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.05 | 11,000 | 561,550 | 38,014 | 49 K to 38 K (-22.44 %) |
Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 11,000 | 79,750 | 49,014 | 38 K to 49 K (+28.94 %) |
Mar 02 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Option Exercise | M | 14.69 | 4,625 | 67,941 | 7,785 | |
Mar 02 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Sell | S | 49.26 | 4,625 | 227,828 | 25,651 | 30.3 K to 25.7 K (-15.28 %) |
Mar 02 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | M | 14.69 | 4,625 | 67,941 | 30,276 | 25.7 K to 30.3 K (+18.03 %) |
Mar 02 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 500 | 5,410 | 3,926 | |
Mar 02 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 49.29 | 1,000 | 49,290 | 11,449 | 12.4 K to 11.4 K (-8.03 %) |
Mar 02 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 49.29 | 500 | 24,645 | 12,449 | 12.9 K to 12.4 K (-3.86 %) |
Mar 02 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 500 | 5,410 | 12,949 | 12.4 K to 12.9 K (+4.02 %) |
Feb 27 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 9.77 | 12,500 | 122,125 | 0 | |
Feb 27 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 9.77 | 12,500 | 122,125 | 88,958 | 76.5 K to 89 K (+16.35 %) |
Feb 08 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 481 | 5,204 | 4,426 | |
Feb 08 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 7.25 | 19 | 138 | 1,200 | |
Feb 08 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 46.50 | 481 | 22,367 | 12,449 | 12.9 K to 12.4 K (-3.72 %) |
Feb 08 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 481 | 5,204 | 12,930 | 12.4 K to 12.9 K (+3.86 %) |
Feb 08 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 46.50 | 19 | 884 | 12,449 | 12.5 K to 12.4 K (-0.15 %) |
Feb 08 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 7.25 | 19 | 138 | 12,468 | 12.4 K to 12.5 K (+0.15 %) |
Feb 08 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 46.00 | 1,000 | 46,004 | 12,449 | 13.4 K to 12.4 K (-7.44 %) |
Feb 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 937 | 0 | 937 | |
Feb 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 937 | 0 | 4,814 | 3.9 K to 4.8 K (+24.17 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | M | 0.00 | 1,295 | 0 | 3,883 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | M | 0.00 | 2,188 | 0 | 4,374 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 0.00 | 7,537 | 0 | 7,537 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Sell | S | 46.29 | 506 | 23,423 | 5,252 | 5.8 K to 5.3 K (-8.79 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | M | 0.00 | 1,295 | 0 | 5,758 | 4.5 K to 5.8 K (+29.02 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Sell | S | 46.29 | 855 | 39,578 | 4,463 | 5.3 K to 4.5 K (-16.08 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | M | 0.00 | 2,188 | 0 | 5,318 | 3.1 K to 5.3 K (+69.90 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 1,594 | 0 | 4,779 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 1,518 | 0 | 3,034 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 1,875 | 0 | 1,875 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | M | 0.00 | 1,415 | 0 | 0 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 46.29 | 623 | 28,839 | 11,772 | 12.4 K to 11.8 K (-5.03 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 1,594 | 0 | 12,395 | 10.8 K to 12.4 K (+14.76 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 46.29 | 593 | 27,451 | 10,801 | 11.4 K to 10.8 K (-5.20 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 1,518 | 0 | 11,394 | 9.9 K to 11.4 K (+15.37 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 46.29 | 733 | 33,931 | 9,876 | 10.6 K to 9.9 K (-6.91 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 1,875 | 0 | 10,609 | 8.7 K to 10.6 K (+21.47 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 46.29 | 553 | 25,598 | 8,734 | 9.3 K to 8.7 K (-5.95 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | M | 0.00 | 1,415 | 0 | 9,287 | 7.9 K to 9.3 K (+17.98 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 1,594 | 0 | 4,779 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 1,311 | 0 | 2,620 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 1,875 | 0 | 1,875 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 653 | 0 | 0 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 312 | 0 | 0 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | A | 0.00 | 7,537 | 0 | 7,537 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 46.29 | 623 | 28,839 | 13,449 | 14.1 K to 13.4 K (-4.43 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 1,594 | 0 | 14,072 | 12.5 K to 14.1 K (+12.77 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 46.29 | 512 | 23,701 | 12,478 | 13 K to 12.5 K (-3.94 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 1,311 | 0 | 12,990 | 11.7 K to 13 K (+11.23 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 46.29 | 733 | 33,931 | 11,679 | 12.4 K to 11.7 K (-5.91 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 1,875 | 0 | 12,412 | 10.5 K to 12.4 K (+17.79 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 46.29 | 256 | 11,850 | 10,537 | 10.8 K to 10.5 K (-2.37 %) |